Growth Metrics

Vertex Pharmaceuticals (VRTX) EPS (Basic) (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Revolution Medicines 31.20 Bn 31.20 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -13.43%
Dec 31, 2025 10.61%
Sep 30, 2025 5.47%
Jun 30, 2025 59.52%
Mar 31, 2025 -28.61%
Dec 31, 2024 -12.84%
Sep 30, 2024 129.09%
Jun 30, 2024 -426.76%
Mar 31, 2024 13.30%
Dec 31, 2023 -6.23%
Sep 30, 2023 12.96%
Jun 30, 2023 30.51%
Mar 31, 2023 -14.73%
Dec 31, 2022 -12.12%
Sep 30, 2022 14.51%
Jun 30, 2022 6.02%
Mar 31, 2022 -0.66%
Dec 31, 2021 -8.79%
Sep 30, 2021 1,169.23%
Jun 30, 2021 -89.68%
Mar 31, 2021 8.62%
Dec 31, 2020 -9.38%
Sep 30, 2020 -20.50%
Jun 30, 2020 38.79%
Mar 31, 2020 2.65%
Dec 31, 2019 927.27%
Sep 30, 2019 -78.85%
Jun 30, 2019 -0.95%
Mar 31, 2019 -82.73%
Dec 31, 2018 1,092.16%
Sep 30, 2018 -37.80%
Jun 30, 2018 -1.20%
Mar 31, 2018 107.50%
Dec 31, 2017 197.56%
Sep 30, 2017 -685.71%
Jun 30, 2017 -93.07%
Mar 31, 2017 676.92%
Dec 31, 2016 181.25%
Sep 30, 2016 38.46%
Jun 30, 2016 -52.94%
Mar 31, 2016 45.16%
Dec 31, 2015 20.51%
Sep 30, 2015 50.00%
Jun 30, 2015 6.02%
Mar 31, 2015 -12.16%
Dec 31, 2014 -2.78%
Sep 30, 2014 -5.88%
Jun 30, 2014 32.00%
Mar 31, 2014 -626.32%
Dec 31, 2013 135.85%
Sep 30, 2013 -103.85%
Jun 30, 2013 81.82%
Mar 31, 2013 -308.57%
Dec 31, 2012 -29.63%
Sep 30, 2012 12.90%
Jun 30, 2012 -170.45%
Mar 31, 2012 -42.11%
Dec 31, 2011 -28.30%
Mar 31, 2011 3.33%
Dec 31, 2010 13.46%
Sep 30, 2010 -4.00%
Jun 30, 2010 -20.48%
Mar 31, 2010 3.49%
Dec 31, 2009 -2.38%
Sep 30, 2009 15.15%
Jun 30, 2009 4.81%